Thomasville National Bank’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $383K | Sell |
2,780
-34
| -1% | -$4.45K | 0.02% | 183 |
|
|
2025
Q3 | $361K | Hold |
2,814
| – | – | 0.02% | 191 |
|
|
2025
Q2 | $341K | Sell |
2,814
-130
| -4% | -$14.7K | 0.02% | 186 |
|
|
2025
Q1 | $328K | Hold |
2,944
| – | – | 0.02% | 190 |
|
|
2024
Q4 | $286K | Sell |
2,944
-380
| -11% | -$40.5K | 0.02% | 199 |
|
|
2024
Q3 | $382K | Sell |
3,324
-544
| -14% | -$61.7K | 0.03% | 184 |
|
|
2024
Q2 | $412K | Buy |
3,868
+290
| +8% | +$29.1K | 0.03% | 166 |
|
|
2024
Q1 | $346K | Sell |
3,578
-77
| -2% | -$7.89K | 0.03% | 180 |
|
|
2023
Q4 | $369K | Sell |
3,655
-2,455
| -40% | -$237K | 0.03% | 178 |
|
|
2023
Q3 | $622K | Buy |
6,110
+66
| +1% | +$6.7K | 0.06% | 133 |
|
|
2023
Q2 | $610K | Sell |
6,044
-80
| -1% | -$8K | 0.06% | 144 |
|
|
2023
Q1 | $563K | Sell |
6,124
-405
| -6% | -$35.4K | 0.06% | 148 |
|
|
2022
Q4 | $592K | Sell |
6,529
-146
| -2% | -$12.3K | 0.07% | 131 |
|
|
2022
Q3 | $507K | Buy |
6,675
+96
| +1% | +$7.96K | 0.06% | 136 |
|
|
2022
Q2 | $556K | Sell |
6,579
-115
| -2% | -$10.1K | 0.06% | 133 |
|
|
2022
Q1 | $587K | Hold |
6,694
| – | – | 0.06% | 139 |
|
|
2021
Q4 | $586K | Sell |
6,694
-474
| -7% | -$39.4K | 0.06% | 142 |
|
|
2021
Q3 | $586K | Sell |
7,168
-1,621
| -18% | -$146K | 0.06% | 140 |
|
|
2021
Q2 | $802K | Buy |
8,789
+314
| +4% | +$28K | 0.09% | 118 |
|
|
2021
Q1 | $699K | Buy |
8,475
+1,900
| +29% | +$171K | 0.13% | 100 |
|
|
2020
Q4 | $621K | Sell |
6,575
-404
| -6% | -$35.3K | 0.08% | 121 |
|
|
2020
Q3 | $607K | Sell |
6,979
-1,327
| -16% | -$115K | 0.09% | 114 |
|
|
2020
Q2 | $725K | Sell |
8,306
-10,495
| -56% | -$906K | 0.11% | 102 |
|
|
2020
Q1 | $1.63M | Sell |
18,801
-65
| -0.3% | -$5.8K | 0.27% | 71 |
|
|
2019
Q4 | $1.79M | Buy |
18,866
+65
| +0.3% | +$5.83K | 0.28% | 64 |
|
|
2019
Q3 | $1.63M | Sell |
18,801
-96,442
| -84% | -$8.66M | 0.27% | 71 |
|
|
2019
Q2 | $10.5M | Sell |
115,243
-13,233
| -10% | -$1.12M | 1.82% | 20 |
|
|
2019
Q1 | $11.1M | Buy |
128,476
+2,786
| +2% | +$224K | 2.04% | 18 |
|
|
2018
Q4 | $9.66M | Sell |
125,690
-3,093
| -2% | -$241K | 1.98% | 18 |
|
|
2018
Q3 | $9.94M | Sell |
128,783
-1,733
| -1% | -$128K | 1.6% | 23 |
|
|
2018
Q2 | $8.84M | Buy |
130,516
+1,234
| +1% | +$85.2K | 1.52% | 23 |
|
|
2018
Q1 | $9.37M | Buy |
129,282
+4,595
| +4% | +$350K | 1.67% | 23 |
|
|
2017
Q4 | $9.38M | Sell |
124,687
-317
| -0.3% | -$23.9K | 1.76% | 19 |
|
|
2017
Q3 | $9.62M | Buy |
125,004
+1,921
| +2% | +$145K | 1.6% | 19 |
|
|
2017
Q2 | $9.21M | Buy |
123,083
+18,163
| +17% | +$1.29M | 1.68% | 20 |
|
|
2017
Q1 | $6.98M | Buy |
+104,920
| New | +$6.99M | 1.39% | 24 |
|
|
2016
Q3 | – | Sell |
-56,356
| Closed | -$4.17M | – | 121 |
|
|
2016
Q2 | $4.17M | Buy |
+56,356
| New | +$3.89M | 1.1% | 32 |
|
|
2015
Q2 | – | Sell |
-279
| Closed | -$25K | – | 268 |
|
|
2015
Q1 | $25K | Buy |
+279
| New | +$24.7K | 0.01% | 264 |
|
|
2014
Q2 | – | Sell |
-59,385
| Closed | -$4.52M | – | 140 |
|
|
2014
Q1 | $4.52M | Sell |
59,385
-569
| -0.9% | -$41.5K | 1.86% | 20 |
|
|
2013
Q4 | $4.32M | Buy |
59,954
+6,094
| +11% | +$424K | 1.9% | 20 |
|
|
2013
Q3 | $3.7M | Sell |
53,860
-51,468
| -49% | -$3.41M | 1.93% | 19 |
|
|
2013
Q2 | $6.67M | Buy |
+105,328
| New | +$6.85M | 4.39% | 3 |
|
Other funds holding NVS
Thomasville National Bank's NVS Position: Q4 2025 in Review
Thomasville National Bank reduced its Novartis (NVS) stake by 1.2% in Q4 2025, selling an estimated $4.45K and leaving 2,780 shares worth $383K. The position accounts for 0.02% of the portfolio, ranked #183.
Thomasville National Bank first reported a position in NVS in Q2 2013 and has held it in 42 quarters since. The position peaked at $11.1M in Q1 2019. 1,509 funds tracked by Wall St. Rank hold NVS as of Q4 2025.
- Thomasville National Bank held 2,780 shares of Novartis worth $383K as of Q4 2025.
- Thomasville National Bank sold 34 Novartis shares in Q4 2025, an estimated $4.45K.
- Novartis made up 0.02% of Thomasville National Bank's portfolio in Q4 2025, its #183 holding.
- Thomasville National Bank first reported a position in Novartis in Q2 2013 and has held it in 42 quarters since.
- Thomasville National Bank's Novartis position peaked at $11.1M in Q1 2019.
- 1,509 funds tracked by Wall St. Rank held Novartis as of Q4 2025.
Based on Thomasville National Bank's 13F filing for Q4 2025, filed 26 Jan 2026.